Nebula Research & Development’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,887
Closed -$194K 39
2025
Q2
$194K Buy
+13,887
New +$224K 0.02% 894
2024
Q2
Sell
-12,296
Closed -$61K 788
2024
Q1
$61K Buy
+12,296
New +$78.7K 0.01% 701

Other funds holding ALHC

Nebula Research & Development's ALHC Position: Q3 2025 in Review

Nebula Research & Development sold out of Alignment Healthcare (ALHC) in Q3 2025, closing a stake of 13,887 shares — an estimated $194K sold.

Nebula Research & Development first reported a position in ALHC in Q1 2024 and held it in 2 quarters. The position peaked at $194K in Q2 2025. 236 funds tracked by Wall St. Rank hold ALHC as of Q3 2025.

  • Nebula Research & Development reported no remaining Alignment Healthcare position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 13,887 Alignment Healthcare shares in Q3 2025, an estimated $194K.
  • Nebula Research & Development first reported a position in Alignment Healthcare in Q1 2024 and held it in 2 quarters.
  • Nebula Research & Development's Alignment Healthcare position peaked at $194K in Q2 2025.
  • 236 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.